在儿童中血动力学妥协的心病:一个范围审查
Amanda J O'Halloran1,2,3, James Gray4,5, Seth Gray6,7
1Department of Anesthesiology and Critical Care Medicine, University of Pennsylvania Perelman School of Medicine, 3400 Civic Center Blvd, Philadelphia, PA 19104, USA.
Resuscitation plus
|December 4, 2025
概括
患有血液动力学损害的儿科心肌梗塞是常见的. 虽然CPR可以提高生存率,但对上腺素和上腺素等特定治疗方法的证据有限,需要进一步研究.
科学领域:
- 儿科复苏 儿科复苏 儿科复苏
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
背景情况:
- 血动力学损害的胸心是儿科住院心脏骤停中最常见的初始节奏.
- 关于这种疾病的各种治疗方法的有效性,存在重大知识差距.
- 本范围审查涉及儿童复苏中证据评估的必要性.
研究的目的:
- 识别和评估现有的关于治疗儿科血动力学妥协的胸肌梗塞的文献.
- 通知国际复苏联络委员会关于复苏的持续证据评估过程.
主要方法:
- 在Medline,EMBASE和Cochrane数据库中进行了全面的搜索.
- 包括涉及患有胸肌梗塞 (<60毫分钟或低于年龄) 和血液动力学损害的儿童的研究.
- 关于研究设计,人群,干预措施,比较器和结果的数据来自27项观察性研究.
主要成果:
- 26项研究表明,在综合性方案中接受心肺复苏的儿童的生存率高于无脉节律的儿童.
- 关于心肺复苏期间使用上腺素和临床结果,报告了相互矛盾的关联.
- 有限的数据存在于阿特罗平的使用;没有研究评估氧气,通风或皮肤穿越节奏.
结论:
- 目前,没有足够的证据支持对患有血动力学损害的儿科心肌梗塞的任何治疗策略进行系统审查.
- 现有的指导方针严重依赖于有限的证据和专家意见.
- 需要进行比较试验来评估这种儿科紧急情况的治疗方法.
相关概念视频
Decreased pulse rate
824
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
824
Dysrhythmias IV: Characteristics of Bradyarrhythmias
474
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
474
Cardiopulmonary Resuscitation IV: Pharmacological Management
595
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
595
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
1.5K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.5K
Pre-Procedural Guidelines for Assessing Blood Pressure
791
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
791
Dysrhythmias VI: Management of Dysrhythmias
414
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
414


